fashion -WSS

fashion

author：focus 2025-09-07 00:19:49 - browse：12

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Why do women spend more than men on medical expenses?

WSS

Address the ethical violations that led to 'Three Identical Strangers'

Sudafed saga points to U.S. issues with evaluating older drugs

Biogen shutters digital health group, ends Apple study, in cost cutting move

The debate over Covid

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Companies helping big Covid

entertainment

fashion

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Continuity nursing helped my family in our darkest PICU moments

Shingles, which affected Dianne Feinstein, is on the rise

How one medical school became remarkably diverse

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Cancer drug shortages should be causing more outrage

Grail's uphill battle for Medicare to cover its cancer screening test

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Address the ethical violations that led to 'Three Identical Strangers'

leisure time

The debate over Covid

Inflation cooled significantly in June, bringing price hikes close to normal levels

Paxlovid should be available without a positive Covid test

The debate over Covid

Inflation cooled significantly in June, bringing price hikes close to normal levels

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

focus

explore

entertainment

Wikipedia